BioDrugs

SJR Rank #897H-index: 90SJR: 2.628Best quartile: Q1APC: US$5,190
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.71.42.12.8

Subject Categories

  • BiotechnologyQ1
  • Medicine (miscellaneous)Q1
  • PharmacologyQ1
  • Pharmacology (medical)Q1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchRheumatoid Arthritis Research and TherapiesImmunotherapy and Immune ResponsesCAR-T cell therapy researchAsthma and respiratory diseasesSystemic Lupus Erythematosus ResearchInflammatory Bowel DiseaseRNA Interference and Gene DeliveryPharmaceutical Economics and Policy

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

20222025015304560

Detailed Information

ISSN

1173-8804, 1179-190X

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

8.60

References per Document

93.63

Coverage

1996-2026

Scope

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes: - Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. - Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. - Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. - Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.

Metrics from SCImago Journal Rank 2025. View on SCImago